We describe the advantages and diagnostic/prognostic significance of low-field, near-portable benchtop NMR spectrometers for the multicomponent metabolomics analysis of targeted and untargeted urinary biomarkers (≥15) in type 2 diabetes patients. Implementation of these facilities at 'point-of-care' clinical sites may yield valuable advantages for the sequential monitoring of diabetic and prediabetic individuals.
Keywords: Biomarkers; NMR-based metabolomics; Non-stationary benchtop 60 MHz NMR analysis; Prediabetes; Type 2 diabetes.
Copyright © 2020. Published by Elsevier B.V.